myBioma is a biotechnology and healthcare startup based in Austria, founded in 2018. The company's slogan, "Scientific gut microbiome analysis," reflects its core focus on providing advanced gut microbiome diagnostics to the public. This is achieved through self-tests based on stool probes, allowing customers to access personalized reports that help them understand the cause of their problems and improve their well-being based on their gut composition.
With a vision to offer state-of-the-art advice to customers, myBioma continuously incorporates the latest high-impact research into the analysis of the stool probes. This approach demonstrates the company's commitment to staying at the forefront of scientific advancements in microbiome analysis, enhancing the value it offers to its customers.
As of now, there is no public information available about the last investment received by myBioma or the investors involved. However, given the growing importance of microbiome analysis in healthcare and wellness, the potential for myBioma to attract investment and expand its operations is significant, especially as it continues to demonstrate the practical applications of its scientific insights.